In This Episode
Oxford University’s vaccine could be up to 90 per cent effective, data from phase III trials shows today. With the UK government ordering 100 million doses of the jab, could it mean a return to normality is on the horizon? Katy Balls speaks to Fraser Nelson and James Forsyth.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in